Blood drug levels may predict recovery after brain bleed
NCT ID NCT07065903
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks 500 adults in Canada and the US who have had a brain aneurysm bleed and are taking the drug nimodipine. Researchers will measure how much of the drug gets into each patient's blood and see how that relates to their recovery 90 days later. The goal is to understand if different doses or forms of nimodipine affect outcomes, which could lead to more personalized treatment in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nimodipine
What this could lead to
If successful, this could lead to personalized nimodipine dosing for patients with brain aneurysm bleeds, potentially improving recovery and reducing disability.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may show associations but not prove cause and effect.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUBARACHNOID HEMORRHAGE, ANEURYSMAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Health Network - Toronto Western Hospital
RECRUITINGToronto, Ontario, M5T 2S8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Alberta Hospital
RECRUITINGEdmonton, Alberta, T6G 2X8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
VCU Medical Center
RECRUITINGRichmond, Virginia, 23219, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••